U.S was International Stem Cell’s largest region in fiscal 2025, bringing in $5.10M of $6.90M (74%).
| Geography | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | — | — | — | — | ||||||||||
| U.S | $4.57M | $4.06M | $5.26M | $5.10M | ||||||||||
| International | $618.00K | $1.89M | $696.00K | $535.00K | ||||||||||
| Ous | — | — | — | — | ||||||||||
| Asia | $690.00K | $726.00K | $890.00K | $719.00K | ||||||||||
| Europe | $393.00K | $395.00K | $407.00K | $448.00K | ||||||||||
| All Other Regions | $81.00K | $120.00K | $61.00K | $95.00K | ||||||||||
| Total | $6.35M | $7.19M | $7.31M | $6.90M |
International Stem Cell brought in $6.90M from its five regions in fiscal 2025, the year ended December 31, 2025. That is less than the $8.50M it reports by segment, so these regions do not cover all of its revenue. U.S was the largest at $5.10M (73.9%), ahead of Asia at $719.00K (10.4%) and International at $535.00K (7.8%). The other two regions brought in $543.00K combined.
Compared with fiscal 2024, Europe grew fastest, up 10.1% to $448.00K, while International fell the most, down 23.1% to $535.00K.
Media was International Stem Cell’s largest segment in fiscal 2025, bringing in $5.81M of $8.50M (68%).
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Media | $5.19M | $4.06M | $5.95M | $5.81M | |||||
| Cells | $1.94M | $3.73M | $2.34M | $2.70M | |||||
| Ecommerce | — | — | — | — | |||||
| Professional | — | — | — | — | |||||
| Other | — | — | — | — | |||||
| International | — | — | — | — | |||||
| Total | $7.13M | $7.79M | $8.29M | $8.50M |
International Stem Cell brought in $8.50M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 2.6% from $8.29M in fiscal 2024. Media was the largest at $5.81M (68.3%), ahead of Cells at $2.70M (31.7%).
Compared with fiscal 2024, Cells grew 15.4% to $2.70M, while Media fell 2.5% to $5.81M. From fiscal 2022 to 2025, combined revenue from these segments grew from $7.13M to $8.50M, a compound annual growth rate of 6.0%. Media's share of the total fell from 72.8% to 68.3%.
Biomedical Market was International Stem Cell’s largest segment in fiscal 2025, bringing in $6.34M of $7.54M (84%).
| Statement Business Segments | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedical Market | $4.57M | $5.26M | $6.59M | $6.34M | ||||||||||
| Cosmeceutical Market | — | — | — | — | ||||||||||
| Cosmetic Market | — | — | — | — | ||||||||||
| Anti-Aging Skincare Market | $1.05M | $923.00K | $795.00K | $598.00K | ||||||||||
| Anti-Aging Market | $1.05M | $923.00K | $795.00K | $598.00K | ||||||||||
| Total | $6.67M | $7.11M | $8.18M | $7.54M |
International Stem Cell brought in $7.54M from its three segments in fiscal 2025, the year ended December 31, 2025. That is less than the $8.50M it reports by segment, so these segments do not cover all of its revenue. Biomedical Market was the largest at $6.34M (84.1%), ahead of Anti-Aging Skincare Market at $598.00K (7.9%) and Anti-Aging Market at $598.00K (7.9%).
Compared with fiscal 2024, every segment above 2% of revenue shrank. Biomedical Market held up best, down 3.7% to $6.34M, and Anti-Aging Market fell the most, down 24.8% to $598.00K.
International Stem Cell (ISCO) reports its revenue by geography, by segment and by statement business segments. In fiscal 2025, U.S was its largest region, bringing in $5.10M (73.9% of the total), followed by Asia at $719.00K (10.4%).
U.S was International Stem Cell's largest region in fiscal 2025, bringing in $5.10M, or 73.9% of the $6.90M total across its five regions.
Media was International Stem Cell's largest segment in fiscal 2025, bringing in $5.81M, or 68.3% of the $8.50M total across its two segments.
Among International Stem Cell's regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 10.1% from $407.00K to $448.00K.
Every figure comes from International Stem Cell's annual financial filings, as reported. Each line keeps the name International Stem Cell gives it, and years follow its fiscal calendar.
International Stem Cell's revenue by geography goes back to fiscal 2012, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.